CLINICAL_TRIALS ClinicalTrials.gov record update

An Open, Multi-dose, Dose Escalation and Cohort Expansion, Phase Ⅰ Study of the Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03852823
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:12.445766+00:00
Published At: 2021-04-30T00:00:00+00:00
Record Updated At: 2021-04-30
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Advanced Solid Tumours", "Cervical Cancer", "Malignant Mesothelioma", "Lymphoma", "Non-Small-Cell Lung Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-04-30"
protocolSection.identificationModule.nctId: "NCT03852823"
protocolSection.identificationModule.officialTitle: "An Open, Multi-dose, Dose Escalation and Cohort Expansion, Phase \u2160 Study of the Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours."
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.